Free Trial
NASDAQ:APYX

Apyx Medical (APYX) Stock Price, News & Analysis

Apyx Medical logo
$1.75 -0.16 (-8.38%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.75 0.00 (0.00%)
As of 08/1/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Apyx Medical Stock (NASDAQ:APYX)

Key Stats

Today's Range
$1.59
$1.94
50-Day Range
$1.54
$2.58
52-Week Range
$0.76
$2.73
Volume
117,927 shs
Average Volume
116,511 shs
Market Capitalization
$66.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Apyx Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

APYX MarketRank™: 

Apyx Medical scored higher than 22% of companies evaluated by MarketBeat, and ranked 829th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Apyx Medical are expected to grow in the coming year, from ($0.68) to ($0.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Apyx Medical is -3.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Apyx Medical is -3.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Apyx Medical has a P/B Ratio of 4.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Apyx Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.93% of the float of Apyx Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Apyx Medical has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Apyx Medical has recently increased by 44.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Apyx Medical does not currently pay a dividend.

  • Dividend Growth

    Apyx Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.93% of the float of Apyx Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Apyx Medical has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Apyx Medical has recently increased by 44.33%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Apyx Medical this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Apyx Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.20% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Apyx Medical's insider trading history.
Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Stock News Headlines

Microsoft's Next Big Bet?
Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space. While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded.
Apyx Medical Corporation (APYX) - Yahoo Finance
See More Headlines

APYX Stock Analysis - Frequently Asked Questions

Apyx Medical's stock was trading at $1.58 at the start of the year. Since then, APYX shares have increased by 10.8% and is now trading at $1.75.

Apyx Medical Corporation (NASDAQ:APYX) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.03. The firm had revenue of $9.43 million for the quarter, compared to analysts' expectations of $9.39 million. Apyx Medical had a negative trailing twelve-month return on equity of 156.85% and a negative net margin of 42.37%.
Read the conference call transcript
.

Top institutional investors of Apyx Medical include Silverberg Bernstein Capital Management LLC (2.37%) and Taylor Frigon Capital Management LLC (1.27%). Insiders that own company stock include Charles D Goodwin II and Todd Hornsby.
View institutional ownership trends
.

Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apyx Medical investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/08/2025
Today
8/02/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:APYX
CIK
719135
Employees
270
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.55)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.46 million
Net Margins
-42.37%
Pretax Margin
-42.07%
Return on Equity
-156.85%
Return on Assets
-31.92%

Debt

Debt-to-Equity Ratio
3.21
Current Ratio
5.45
Quick Ratio
4.64

Sales & Book Value

Annual Sales
$48.10 million
Price / Sales
1.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.38 per share
Price / Book
4.61

Miscellaneous

Outstanding Shares
37,790,000
Free Float
32,049,000
Market Cap
$66.13 million
Optionable
Optionable
Beta
1.39

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:APYX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners